Providing market intelligence for more than 35 years

In The News

YouTube TV: Millennials will love TV on their phones, trust us!

YouTube TV is also available to watch on laptop and desktop computers, which for many young people equates to the biggest screen in the house.

But at launch, YouTube TV doesn't have support for other streaming devices like Roku or Amazon Fire TV, even though those products are more popular than Chromecast. According to the most recent data from researcher Parks Associates, Roku was the most-purchased line of streaming media players in the US, with a 30 percent share. Amazon's devices just beat out Chromecast, with a 22 percent of sales compared with Chromecast's 21 percent. Apple TV followed at 20 percent.

When CNET asked why YouTube TV is emphasizing mobile even though consumer behavior seems to go the other way, YouTube said that more device support was coming.

From the article "YouTube TV: Millennials will love TV on their phones, trust us!" by Joan E. Solsman.

Previously In The News

Samsung Leads in 4K TV Sales, Report Shows

Parks reported that 19 percent of U.S. broadband households intend to purchase a flat-panel TV set by the end of 2015. Roughly 40 percent of those households are looking for a 4K TV set, which is appr...

Cord Cutters Face A Sea Of Streaming Options

Hartstein’s decision was made easier because of a flood of Internet streaming services that allows consumers to cobble together their own video packages. There are more than 100 Internet video service...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...